According to Zacks, “RPX Corporation is a provider of patent risk solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services. The Company provides a subscription-based patent risk management solution where by acquiring patents it mitigates and manages patent risk. It also provides to its clients access to its proprietary patent market intelligence and data. Its clientele compromise companies that design, make or sell technology-based products and services as well as companies that use technology in their businesses. RPX Corporation is based in San Francisco, California. “
Separately, Barclays PLC cut their price objective on shares of RPX Corp. from $10.00 to $9.00 and set an underweight rating for the company in a research report on Thursday, July 7th.
RPX Corp. (NASDAQ:RPXC) opened at 10.46 on Wednesday. The company has a market cap of $518.39 million, a price-to-earnings ratio of 26.02 and a beta of 1.10. The company’s 50-day moving average is $10.50 and its 200 day moving average is $10.26. RPX Corp. has a 1-year low of $8.60 and a 1-year high of $15.41.
RPX Corp. (NASDAQ:RPXC) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.05. RPX Corp. had a net margin of 7.16% and a return on equity of 4.95%. The business earned $83.10 million during the quarter, compared to analysts’ expectations of $82.14 million. During the same quarter in the prior year, the business posted $0.20 earnings per share. RPX Corp.’s revenue was up 22.9% compared to the same quarter last year. On average, equities analysts predict that RPX Corp. will post $0.75 EPS for the current fiscal year.
In other news, insider Mallun Yen sold 8,155 shares of the stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $10.63, for a total value of $86,687.65. Following the completion of the transaction, the insider now owns 109,642 shares of the company’s stock, valued at $1,165,494.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert H. Heath sold 3,000 shares of the stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $10.60, for a total transaction of $31,800.00. Following the completion of the transaction, the chief financial officer now directly owns 79,437 shares of the company’s stock, valued at approximately $842,032.20. The disclosure for this sale can be found here. 6.89% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Emerald Acquisition Ltd. bought a new position in RPX Corp. during the second quarter worth approximately $3,630,000. Renaissance Technologies LLC increased its position in RPX Corp. by 27.5% in the first quarter. Renaissance Technologies LLC now owns 1,707,500 shares of the company’s stock valued at $19,226,000 after buying an additional 368,700 shares in the last quarter. Bank of Montreal Can purchased a new position in RPX Corp. during the second quarter valued at about $3,247,000. Thompson Siegel & Walmsley LLC increased its position in RPX Corp. by 21.1% in the second quarter. Thompson Siegel & Walmsley LLC now owns 1,139,263 shares of the company’s stock valued at $10,447,000 after buying an additional 198,683 shares in the last quarter. Finally, Royal Bank of Canada increased its position in RPX Corp. by 1,267.9% in the second quarter. Royal Bank of Canada now owns 191,500 shares of the company’s stock valued at $1,756,000 after buying an additional 177,500 shares in the last quarter. 88.07% of the stock is owned by hedge funds and other institutional investors.
RPX Corp. Company Profile
RPX Corporation offers patent risk management solutions. The Company’s patent risk management solution facilitates exchanges of value between owners and users of patents. The core of its solution is defensive patent aggregation, in which the Company acquires patents and licenses to patents that are being or may be asserted against its clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RPX Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPX Corp. and related companies with MarketBeat.com's FREE daily email newsletter.